Webinar report - The renaissance of neuroprotection in times of recanalization therapies

Advances in acute stroke treatment within the last 25 years have mainly been made in recanalization therapies, particularly with the approval of rtPA and thrombectomy devices. In order to establish evidence if Cerebrolysin^®, when combined with rtPA and/or thrombectomy, can add safety or better outcome, several preclinical and clinical development initiatives were either already published or can be expected soon. The speakers of the webinar are all deeply involved in this research program and gave an update on the current evidence.

Please find the summary of the lectures in the report below. The full recording of the event can be viewed on https://webinars-everpharma.com.